- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Wilson disease
- Meeting Date: May 2022
- Public Summary Document (PSD) May 2022 PBAC Meeting - (PDF 574KB)
- Public Summary Document (PSD) May 2022 PBAC Meeting - (Word 92KB)
Trientine – May 2022
Trientine: Tablet 150 mg (as tetrahydrochloride); Cuprior® – May 2022
Last updated
26 August 2022